EirSystems secures seed funding in round led by Solas BioVentures
One might call this one neighbor helping another.
EirSystems, a Chattanooga-based provider of software for prescribing and distributing prescriptions, has raised an undisclosed amount in seed funding in a round led by Chattanooga’s Solas BioVentures. Chain Reaction Boston investors, led by Ken Mooney, also participated.
Founded in 2018 by brothers Ryan and Tyler Seaberg, EirSystems provides P.A.G.R. (Prescription Abuse Greatly Reduced) software tools to make prescribing medications simple, safe, and efficient for doctors and their patients. P.A.G.R. can be integrated or installed into any system and operates in one easy-to-use web interface. The company currently serves customers in numerous sectors of the healthcare market, including hospice, home health, small and medium-sized clinics, and telehealth platforms.
“We are incredibly grateful to work with Solas BioVentures and Chain Reaction to secure our latest funding round. We believe our partnership with Solas will allow EirSystems to make more partnerships in the healthcare industry, allowing our product to grow quickly over the next few years,” EirSystems Chief Executive Officer Tyler Seaberg said in this news release. “Specifically, this funding will enable us to ramp up production, expand our support teams by hiring talent from the Chattanooga area and, in 2023, release new product offerings for medication management and prescription drug claims designed to impact the prescribing space significantly.”
David Adair, Co-Founder and Managing Partner at Solas BioVentures, said that “EirSystems’ innovation in the ePrescription market is second to none. This technology will help physicians better serve their patients’ well-being with faster and more accurate information at hand.”
